Biomark Diagnostics (XCNQ:BUX) Deferred Tax : C$0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Biomark Diagnostics Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Biomark Diagnostics's change in deferred tax for the three months ended in Jun. 2024 was C$0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Jun. 2024 was C$0.00 Mil.

Biomark Diagnostics Deferred Tax Historical Data

The historical data trend for Biomark Diagnostics's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomark Diagnostics Deferred Tax Chart

Biomark Diagnostics Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Deferred Tax

Get a 7-Day Free Trial

Biomark Diagnostics Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Deferred Tax	Get a 7-Day Free Trial															-	-	-	-	-

Biomark Diagnostics Deferred Tax Calculation

Deferred Tax for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Biomark Diagnostics Deferred Tax Related Terms

Thank you for viewing the detailed overview of Biomark Diagnostics's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomark Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomark Diagnostics Inc (XCNQ:BUX) » Definitions » Deferred Tax

Comparable Companies

Traded in Other Exchanges

BMKDF:USA 20B:Germany

Address

130 - 3851 Shell Road, Richmond, BC, CAN, V6X 2W2

Website

https://www.biomarkdiagnostics.com

Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection. It is currently focused on bringing its liquid biopsy-based cancer diagnostic tests and detection solution to commercialization.

Executives

Rashid Ahmed Maula Bux	Director
Guoyu Huang	Senior Officer

Biomark Diagnostics Headlines

No Headlines